美股詳情

本頁面由Tiger Trade Technology Pte. Ltd.提供服務

生物科技指數ETF-iShares Nasdaq

202.40

+0.40000.20%

盤後：201.76-0.6400-0.32%17:59 EDT

成交量：109.86萬

成交額：2.23億

市值：103.12億

市盈率：32.07

高：204.16

開：202.49

低：200.98

收：202.00

52周最高：217.12

52周最低：138.79

股本：5,095.00萬

流通股本：5,095.00萬

量比：0.64

換手率：2.16%

股息：0.40

股息率：0.20%

每股收益(TTM):6.31

每股收益(LYR):35.34

淨資產收益率：24.54%

總資產收益率：0.10%

市淨率：1.27

市盈率(LYR):5.73

資料載入中...

總覽公司新聞資訊公告

盤前異動：安進、耐克、Bloom Energy 等個股受關注

美股異動｜安進盤前跌5.4%，諾華同靶點藥物III期臨床失敗，Lp(a)賽道遭重創

安進股價盤前下跌5.4%；競爭對手諾華的膽固醇藥物後期臨床試驗失敗。

山德士擬投資3億美元在斯洛文尼亞建設生物類似藥原料藥工廠

山德士擬投資3億美元在斯洛文尼亞建設生物類似藥原料藥工廠

富國銀行上調安進目標價至435美元

諾華降膽固醇藥物遭遇挫折，令人們對新興心臟病藥物的期望蒙上陰影

一周兩度受挫！諾華(NVS.US)心臟病重磅藥III期折戟，股價大跌安進(AMGN.US)「躺槍」

安進（AMGN）罕見病藥物Tavneos將於27年3月1日被徹底撤銷英國上市許可

高盛9月「確信名單」更新：美股納入福泰製藥(VRTX.US) 歐股力推萊茵、Adyen和塔蘭克斯

高盛9月「確信名單」更新：美股納入福泰製藥歐股力推萊茵、Adyen和塔蘭克斯

美股異動丨諾華製藥升逾7%，多發性硬化症口服藥後期臨床試驗結果積極

英國監管機構因數據不可靠，暫停安進公司Tavneos用於新患者

英國藥品與健康產品管理局：通知上市許可持有方，自9月1日起暫停新患者使用、供應及銷售Avacopan Vifor

特朗普政府將宣佈藥品定價協議

安進（AMGN）降脂藥Repatha新臨床數據：可降低未發生心梗或中風高危患者20%死亡風險

藥聞 | 英硅智能上市後首份半年報扭虧創新藥研發加速擁抱AI

聯環藥業上半年扭虧為盈集採續採與創新藥研發協同推進

台裕製藥提交針對HER2陽性乳腺癌的抗體藥物偶聯物生物類似藥TSY-110的臨床試驗申請。

美國食品藥品監督管理局（FDA）批准吉利德治療艾滋病的每日一次複方片劑

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"Easy breezy. No more feesies.","description":"Tiger Trade is a mobile trading app offering real time data, low commission fees and a free demo account. Download now to start investing in ETFs, options and the global share market.","keywords":"老虎國際,美股交易,港股交易,交易美股,股票信息,股價,美股行情,美股打新,港股打新,IPO打新,購買美股,全球投資","social":{"ogDescription":"Tiger Trade is a mobile trading app offering real time data, low commission fees and a free demo account. Download now to start investing in ETFs, options and the global share market.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.thetigerbrokers.com/hant/stock/IBB/news?page=3"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"NZL","license":"TBKIWI","edition":"fundamental","symbol":"IBB","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"IBB\",,,,,undefined,":{"symbol":"IBB","market":"US","secType":"STK","nameCN":"生物科技指數ETF-iShares Nasdaq","latestPrice":202.4,"timestamp":1789588800000,"preClose":202,"halted":0,"volume":1098586,"hourTrading":{"tag":"盘后","latestPrice":201.76,"preClose":202.4,"latestTime":"17:59 EDT","volume":1021,"amount":206648.22527000002,"timestamp":1789595979429,"change":-0.64,"changeRate":-0.003162,"amplitude":0.009733},"delay":0,"changeRate":0.0019801980198020084,"floatShares":50950000,"shares":50950000,"eps":6.311863,"marketStatus":"盤後交易","change":0.4,"latestTime":"09-16 17:59:42 EDT","open":202.49,"high":204.1599,"low":200.98,"amount":222791768.69476002,"amplitude":0.015742,"askPrice":203.4,"askSize":1802,"bidPrice":201.76,"bidSize":10,"shortable":3,"etf":1,"ttmEps":6.311863,"tradingStatus":3,"nextMarketStatus":{"tag":"收盤","tradingStatus":0,"beginTime":1789603200000},"marketStatusCode":4,"adr":0,"adrRate":0,"exchange":"NASDAQ","adjPreClose":202,"sharesOutstanding":49450000,"nav":204.610559,"aum":10516982732.6,"dividendRate":0.001996,"bidAskSpread":0.000306,"preHourTrading":{"tag":"盘前","latestPrice":203.71,"preClose":202,"latestTime":"09:17 EDT","volume":108,"amount":21996.522,"timestamp":1789564649878,"change":1.71,"changeRate":0.008465,"amplitude":0.010149},"postHourTrading":{"tag":"盘后","latestPrice":201.76,"preClose":202.4,"latestTime":"17:59 EDT","volume":1021,"amount":206648.22527000002,"timestamp":1789595979429,"change":-0.64,"changeRate":-0.003162,"amplitude":0.009733},"volumeRatio":0.642963,"impliedVol":0.2493,"impliedVolPercentile":0.745},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"IBB\",,,,,undefined,":{"symbol":"IBB","floatShares":50950000,"roa":"0.10%","roe":"24.54%","lyrEps":35.344796,"volumeRatio":0.642963,"shares":50950000,"dividePrice":0.404,"high":204.1599,"amplitude":0.015742,"preClose":202,"low":200.98,"week52Low":138.785,"pbRate":"1.27","psRate":"248.11","week52High":217.12,"institutionHeld":0,"latestPrice":202.4,"committee":-0.988962,"eps":6.311863,"divideRate":0.001996,"volume":1098586,"delay":0,"ttmEps":6.311863,"open":202.49,"prevYearClose":168.77,"prevWeekClose":202.93,"prevMonthClose":209.05,"prevQuarterClose":190.19,"fiveDayClose":205.49,"twentyDayClose":203.56,"sixtyDayClose":177},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/IBB\",params:#limit:5,,,undefined,":[{"date":"2026-09-15","symbol":"IBB","amount":0.011194,"announcedDate":"2026-09-14","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-09-15","defaultRemindTime":1789479000000,"name":"生物科技指数ETF-iShares Nasdaq","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-09-18","payableDate":"2026-09-15","currency":"USD","dateTimestamp":1789444800000,"payDate":"2026-09-18"},{"date":"2026-06-15","symbol":"IBB","amount":0.023774,"announcedDate":"2026-06-12","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-06-15","defaultRemindTime":1781530200000,"name":"生物科技指数ETF-iShares Nasdaq","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-06-18","payableDate":"2026-06-15","currency":"USD","dateTimestamp":1781496000000,"payDate":"2026-06-18"},{"date":"2026-03-17","symbol":"IBB","amount":0.121818,"announcedDate":"2026-03-16","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-03-17","defaultRemindTime":1773754200000,"name":"生物科技指数ETF-iShares Nasdaq","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-03-20","payableDate":"2026-03-17","currency":"USD","dateTimestamp":1773720000000,"payDate":"2026-03-20"},{"date":"2025-12-16","symbol":"IBB","amount":0.183099,"announcedDate":"2025-12-15","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-12-16","defaultRemindTime":1765895400000,"name":"生物科技指数ETF-iShares Nasdaq","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-12-19","payableDate":"2025-12-16","currency":"USD","dateTimestamp":1765861200000,"payDate":"2025-12-19"},{"date":"2025-09-16","symbol":"IBB","amount":0.082843,"announcedDate":"2025-09-15","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-09-16","defaultRemindTime":1758029400000,"name":"生物科技指数ETF-iShares Nasdaq","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-09-19","payableDate":"2025-09-16","currency":"USD","dateTimestamp":1757995200000,"payDate":"2025-09-19"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"IBB\",market:\"US\",,,undefined,":[{"executeDate":"2016-09-26","recordDate":"2016-09-28","paymentDate":"2016-09-30","value":0.0858219,"currency":"USD"},{"executeDate":"2016-12-22","recordDate":"2016-12-27","paymentDate":"2016-12-29","value":0.091903,"currency":"USD"},{"executeDate":"2017-03-24","recordDate":"2017-03-28","paymentDate":"2017-03-30","value":0.29898,"currency":"USD"},{"executeDate":"2017-06-27","recordDate":"2017-06-29","paymentDate":"2017-06-30","value":0.176803,"currency":"USD"},{"executeDate":"2017-09-26","recordDate":"2017-09-27","paymentDate":"2017-09-29","value":0.118654,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"IBB\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"IBB\",pageSize:20,pageCount:3,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"1176595225","title":"盤前異動：安進、耐克、Bloom Energy 等個股受關注","url":"https://stock-news.laohu8.com/highlight/detail?id=1176595225","media":"投资观察","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1176595225?lang=zh_tw&edition=fundamental","pubTime":"2026-09-08 17:10","pubTimestamp":1788858632,"startTime":"0","endTime":"0","summary":"安进：这家生物科技巨头、道琼斯指数的重要权重股，其盘前股价重挫逾5%。此前，瑞士制药商诺华宣称，其一款实验性药物在晚期临床试验中未能有效降低心血管风险。安进与礼来目前正在各自研发竞品疗法以应对挑战。消息传出后，诺华在欧股市场大跌10%，礼来股价亦小幅走低。Bloom Energy：这家燃料电池制造商可谓利好连连。受此提振，其盘前股价上扬4%。游戏驿站定于今日美股收盘后发布财报。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["07399","IE00BJT1NW94.SGD","MSTW","LU2098885051.SGD","CRPT","HOOX","BK4599","BK4532","PJP","BPAY","MSST","NVS","CONL","SMST","LU0823414478.USD","HOOZ","COII","ROBN","07799","FIAT","IE00BJJMRZ35.SGD","LU0708994859.HKD","LU2360107671.USD","LU0122379950.USD","MSTK","BBH","LU0058720904.USD","IMST","OWNB","LMI3.UK","BK4561","COIO","BK4533","EGGY","BK4596","LU1057294990.SGD","LU1303367103.USD","LU1861559042.SGD","BK4182","CONY","GMEC","CONX","HODU","LU1267930813.SGD","LU0957808578.USD","BK4127","FDIG","IBLC","07311","MSTZ","LU2249611893.SGD","LU1988902786.USD","LU0070302665.USD","09711","LU2089984988.USD","LU0052756011.USD","APED","BK4541","BK4539","BK4581","LU1861220207.SGD","BK4516","VTWG","MSTR","BK4600","LU0211331839.USD","ICLN","GMEY","IE0009355771.USD","LU0889566641.SGD","BK4146","COIG","CONI","LU0109394709.USD","LU0823414551.USD","LU0868494617.USD","LU2468319806.SGD","IGME","LU0476273544.USD","LU0208291251.USD","NKE","PPH","COYY","09399","LU0128525689.USD","LU0128525929.USD","3SMI.UK","BE","BK4566","LU0289739699.SGD","TBXU","BK4007","SIMS","04332","ICOI","LU1064131342.USD","UPGR","LU2264538146.SGD","LU1642822529.SGD","LU1267930227.SGD","HOOD","MSOO","BK4139","MSTY.UK","BK4558","BK4578","HOOI","BEZ","LU2357125470.USD","MSTP","ZAP","LU0029864427.USD","COIA","IE00BFTCPJ56.SGD","LU2506951792.HKD","SMI3.UK","MSTX","HOYY","LU2543165471.USD","LU1571399168.USD","BITQ","GME","MSDD","IE0009354923.USD","BK4588","HOOW","LU0310800379.SGD","IE00B2B36J28.USD","AMGN","IE0002141913.USD","HOOG","MTYY","BK4585","BK4112","BEX","IE00BFXG0V08.USD","MST","FINX","BLCK","IE00B4R5TH58.HKD","LU1267930573.SGD","LU0823411888.USD","DAPP","LU0889565916.HKD","LU1861558580.USD","BEG","07711","WNTR","BK4554","IE00BYQQ9H92.USD","09799","BK4534","COIN","BK4577","LU0444973449.USD","HOOY","MEDX","MSTU","COIX","CTEC","HOOC","IAI","BK4023","LU2112291526.USD","VCLN","BK4595","LU0320765992.SGD","BKCH","LU0320765489.SGD","LU1815336760.USD","LU1983299246.USD","BK4547","BK4076","LU1061106388.HKD","09311","BK4535","HOII","LU0786609619.USD","BEC","IBBQ","STYL","LU0792757196.USD","SG9999001440.SGD","COIW","IBAT","PBE","LU2294711713.HKD","GMEU","FRNW","LU1861217088.USD","BK4551","3LMI.UK","LU0310800965.SGD","MSTC","WATS","MSTY","CNRG","LU0444971666.USD","SMOG","MSII","LU2242646821.SGD","IBB","BIB","LU1023059063.AUD","LU2242652126.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665326953","title":"美股異動｜安進盤前跌5.4%，諾華同靶點藥物III期臨床失敗，Lp(a)賽道遭重創","url":"https://stock-news.laohu8.com/highlight/detail?id=2665326953","media":"中金财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665326953?lang=zh_tw&edition=fundamental","pubTime":"2026-09-08 17:07","pubTimestamp":1788858422,"startTime":"0","endTime":"0","summary":"消息面上，诺华于9月4日公布，其与Ionis联合开发的降脂药物Pelacarsen，在名为LpHORIZON的III期临床试验中未能达到主要终点。诺华的Pelacarsen是全球首个针对Lp靶点进行心血管结局验证的III期药物。因此，市场担忧情绪蔓延到了同样在开发Lp药物的安进身上。多家分析机构认为，诺华的失败削弱了但并未完全推翻Lp这一靶点的可行性。安进后续公布的Olpasiran完整试验数据，将成为判断该靶点未来走向的关键。","market":"us","thumbnail":" http://caiji.3g.cnfol.com/colect/202609/08/20260908512020.jpg","type":0,"news_type":0,"thumbnails":[" http://caiji.3g.cnfol.com/colect/202609/08/20260908512020.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/gushizhibo/20260908/32363493.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["BK4532","BK4533","IE00B2B36J28.USD","LU0109394709.USD","LU0058720904.USD","BK4588","LU0868494617.USD","IE00B4R5TH58.HKD","TBXU","LU0211331839.USD","BK4581","LU0122379950.USD","IBB","IE0002141913.USD","PPH","IE0009355771.USD","NVS","PBE","LU2242652126.USD","IE00BJT1NW94.SGD","LU0320765489.SGD","LU0320765992.SGD","BK4578","BK4599","LU0289739699.SGD","SG9999001440.SGD","IE00BJJMRZ35.SGD","LU2468319806.SGD","BK4007","LU0070302665.USD","IE00BFTCPJ56.SGD","AMGN","LU0889565916.HKD","LU2112291526.USD","BBH","LU0208291251.USD","LU1983299246.USD","PJP","BK4534","IBBQ","LU1023059063.AUD","BK4139","BK4566","LU2089984988.USD","MEDX","BIB","LU1061106388.HKD","LU1057294990.SGD","BK4585","LU1571399168.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665258833","title":"安進股價盤前下跌5.4%；競爭對手諾華的膽固醇藥物後期臨床試驗失敗。","url":"https://stock-news.laohu8.com/highlight/detail?id=2665258833","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665258833?lang=zh_tw&edition=fundamental","pubTime":"2026-09-08 16:28","pubTimestamp":1788856084,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["IE00BFTCPJ56.SGD","MDTX","PPH","LU0889565916.HKD","BBH","BK4534","LU0122379950.USD","BIB","LU0211331839.USD","BK4007","IBBJ","LU2089984988.USD","SG9999001440.SGD","BK4585","BK4533","BK4578","IBBQ","LU1023059063.AUD","LU2468319806.SGD","IE00BJT1NW94.SGD","NVS","BMED","IE0002141913.USD","LU0320765489.SGD","LU0109394709.USD","LU2242646821.SGD","LU0070302665.USD","LU1061106388.HKD","IBB","LU0320765992.SGD","BK4532","BK4566","LU2242652126.USD","TBXU","LU2112291526.USD","LU1057294990.SGD","AMGN","LU0058720904.USD","PSYK","MEDX","BK4599","IE00BJJMRZ35.SGD","LU0289739699.SGD","PJP","BK4581","LU0868494617.USD","LU1983299246.USD","PBE","LU0208291251.USD","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665425173","title":"山德士擬投資3億美元在斯洛文尼亞建設生物類似藥原料藥工廠","url":"https://stock-news.laohu8.com/highlight/detail?id=2665425173","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665425173?lang=zh_tw&edition=fundamental","pubTime":"2026-09-08 13:24","pubTimestamp":1788845041,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["LU2322448791.USD","LU1992135472.HKD","LU1992135399.USD","XPH","IBB","LU2473716301.USD","LU2272731782.SGD","LU2272731865.HKD","LU2272731600.USD","BK4588","PPH","LU2322448957.HKD","BK4585","IE00B5TLWC47.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665342830","title":"山德士擬投資3億美元在斯洛文尼亞建設生物類似藥原料藥工廠","url":"https://stock-news.laohu8.com/highlight/detail?id=2665342830","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665342830?lang=zh_tw&edition=fundamental","pubTime":"2026-09-08 13:20","pubTimestamp":1788844815,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["IE00B5TLWC47.USD","BK4585","XPH","LU1992135399.USD","LU1992135472.HKD","LU2322448957.HKD","BK4588","LU2473716301.USD","LU2322448791.USD","LU2272731782.SGD","LU2272731865.HKD","IBB","PPH","LU2272731600.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665349003","title":"富國銀行上調安進目標價至435美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2665349003","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665349003?lang=zh_tw&edition=fundamental","pubTime":"2026-09-08 11:12","pubTimestamp":1788837128,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["LU1023059063.AUD","BK4599","LU2242652126.USD","BK4582","IBB","AMGN","UUP","BK4533","LU2112291526.USD","LU2089984988.USD","TBXU","LU0058720904.USD","LU0320765992.SGD","BK4534","BK4581","IE00BJJMRZ35.SGD","BK4139","LU0289739699.SGD","PGF","IE0009355771.USD","IE00B4R5TH58.HKD","IBBQ","PBE","LU2242646821.SGD","IE0002141913.USD","LU1571399168.USD","BIB","LU2468319806.SGD","BK4588","IE00BJT1NW94.SGD","SG9999001440.SGD","IE00BFTCPJ56.SGD","LU1057294990.SGD","LU0889565916.HKD","BK4585","LU0109394709.USD","LU1061106388.HKD","PJP","IE00B2B36J28.USD","UDN","BK4566","BBH","LU0122379950.USD","LU0868494617.USD","LU1983299246.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665699390","title":"諾華降膽固醇藥物遭遇挫折，令人們對新興心臟病藥物的期望蒙上陰影","url":"https://stock-news.laohu8.com/highlight/detail?id=2665699390","media":"路透中文","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665699390?lang=zh_tw&edition=fundamental","pubTime":"2026-09-07 16:11","pubTimestamp":1788768711,"startTime":"0","endTime":"0","summary":"罕见病药物备受期待市场关注点现将转向第四季度其RNA疗法del-desiran的后期临床试验结果。该药物用于治疗一种罕见肌肉疾病，系通过收购Avidity公司获得。诺华公司另一款抗炎药物雷米布替尼针对一种名为脓疱性汗腺炎的皮肤病所开展的研究数据，预计也将于今年公布。该药物上周在多发性硬化症患者的临床试验中取得了成功。这两家竞争对手的药物均在与佩拉卡森类似的临床试验中进行测试，这些试验依赖于确诊的心脏相关事件，且没有明确的结束日期。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260907:nL4T44Z0IF:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IXJ","LLY","LLII","JDOC","FHLC","CANC","PJP","IBB","LU2324357040.USD","IYH","NAMS","PPH","CURE","ELIL","LU0456855351.SGD","GDOC","TMED","IE00BK4W5L77.USD","LU1988902786.USD","VHT","PBE","FTXH","LU2491049909.HKD","BIB","IHE","ELIS","LLYZ","TBXU","ILDR","SLN","AGNG","LU1551013425.SGD","LU2746668974.SGD","AMGN","THNR","LU0096364046.USD","IBBQ","BBH","BK4588","MHIP","XLV","MEDX","MEDI","TRUH","WDNA","BK4581","RXL","OZEM","HRTS","LLYX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665392789","title":"一周兩度受挫！諾華(NVS.US)心臟病重磅藥III期折戟，股價大跌安進(AMGN.US)「躺槍」","url":"https://stock-news.laohu8.com/highlight/detail?id=2665392789","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665392789?lang=zh_tw&edition=fundamental","pubTime":"2026-09-07 15:15","pubTimestamp":1788765302,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，瑞士制药巨头诺华制药再遭临床试验打击——一周之内，该公司第二项重磅候选药物在后期研究中折戟。此次失利的是其潜在明星心脏病药物pelacarsen。受此消息影响，诺华在美上市股票上周五常规交易结束后一度下跌逾7%。开发类似心脏药物的安进股价上周五盘后也下挫近6%。诺华正寄望于一系列新药来支撑增长，以应对旗下多款重磅产品专利即将到期的压力。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1492719.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK4585","LU1057294990.SGD","IBBQ","BK4533","LU2242652126.USD","IE0009355771.USD","BK4007","LU2468319806.SGD","LU0320765992.SGD","NVS","BK4581","LU0070302665.USD","BK4139","LU0211331839.USD","PPH","IE00B2B36J28.USD","MEDX","BK4532","IE00BJT1NW94.SGD","LU2089984988.USD","IE0002141913.USD","LU2112291526.USD","BK4534","LU1571399168.USD","IBB","BK4599","BK4566","IE00BJJMRZ35.SGD","BBH","LU1061106388.HKD","BK4578","LU1023059063.AUD","SG9999001440.SGD","BIB","PBE","AMGN","LU0868494617.USD","IE00B4R5TH58.HKD","BK4588","LU0208291251.USD","IE00BFTCPJ56.SGD","TBXU","LU0109394709.USD","LU0320765489.SGD","LU0122379950.USD","PJP","LU2242646821.SGD","LU0889565916.HKD","LU0289739699.SGD","LU0058720904.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664194548","title":"安進（AMGN）罕見病藥物Tavneos將於27年3月1日被徹底撤銷英國上市許可","url":"https://stock-news.laohu8.com/highlight/detail?id=2664194548","media":"金吾财讯","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664194548?lang=zh_tw&edition=fundamental","pubTime":"2026-09-02 19:59","pubTimestamp":1788350357,"startTime":"0","endTime":"0","summary":"金吾财讯 | 英国药品监管机构MHRA宣布，暂停安进（AMGN）罕见病药物Avacopan Vifor（原商品名Tavneos）用于新患者，监管认定支撑该药物获批的关键临床试验数据已不可靠。该药2022年在英国获批，用于治疗两种罕见血管炎症自身免疫病。安进持有美国地区权益，由CSL集团（CSLLY）旗下CSLVifor负责英国等海外市场销售。新规9月1日落地，不再允许新患者启用该药物；为保障现有患者安全，设置6个月过渡用药期，2027年3月1日将彻底撤销其英国上市许可，现有患者可在此期间逐步更换替代治疗方案。安进方面公开表示不认可监管机构的决定，担忧该举措会对罕见病患者造成负面影响。","market":"hk","thumbnail":"https://static.szfiu.com/news/20210625/OTU2NGE4NGJmZTIzZDc2N2YxYmJkM2MyMjUzODQzOTQ1NzY=.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20210625/OTU2NGE4NGJmZTIzZDc2N2YxYmJkM2MyMjUzODQzOTQ1NzY=.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"305627","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BFTCPJ56.SGD","IPOS","LU0889565916.HKD","BBH","BK4534","LU1571399168.USD","LU0122379950.USD","BIB","IE00B2B36J28.USD","LU2089984988.USD","SG9999001440.SGD","BK4585","BK4533","IBBQ","LU1023059063.AUD","LU2468319806.SGD","IE00BJT1NW94.SGD","IE0002141913.USD","LU2242646821.SGD","LU0109394709.USD","LU1061106388.HKD","IBB","LU0320765992.SGD","BK4566","LU2242652126.USD","TBXU","LU2112291526.USD","AZNH","AMGN","LU0058720904.USD","BK4139","IE0009355771.USD","LU1057294990.SGD","BK4599","IE00BJJMRZ35.SGD","LU0289739699.SGD","IE00B4R5TH58.HKD","PJP","BK4581","LU0868494617.USD","LU1983299246.USD","PBE","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664891714","title":"高盛9月「確信名單」更新：美股納入福泰製藥(VRTX.US) 歐股力推萊茵、Adyen和塔蘭克斯","url":"https://stock-news.laohu8.com/highlight/detail?id=2664891714","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664891714?lang=zh_tw&edition=fundamental","pubTime":"2026-09-02 15:20","pubTimestamp":1788333621,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["LU2471134952.CNY","LU0096364046.USD","LU2324357040.USD","LU0942090050.USD","LU2237443549.SGD","LU1868836591.USD","BK4550","BK4588","LU1674673691.USD","IE0009355771.USD","LU0868494617.USD","LU0432979614.USD","LU2468319806.SGD","SG9999001176.SGD","IE0002141913.USD","LU0251131958.USD","IEV","IBBQ","IE00BJJMRZ35.SGD","BK4585","LU0061475181.USD","GNMX","LU2237438978.USD","PBE","BBH","LU2456880835.USD","LU0289739699.SGD","TBXU","LU1868837300.USD","LU1668664300.SGD","GSX","LU0868494708.USD","VXUS","IE00B19Z9Z06.USD","BK4533","LU2471134523.USD","SG9999001176.USD","IDNA","VRTX","VGK","LU2237443978.SGD","LU1144417596.USD","LU1791807156.HKD","LU2462157665.USD","LU1868836914.USD","BK4127","IBB","IE00BZ9MQY76.HKD","BIB","IE00B19Z9P08.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664891705","title":"高盛9月「確信名單」更新：美股納入福泰製藥 歐股力推萊茵、Adyen和塔蘭克斯","url":"https://stock-news.laohu8.com/highlight/detail?id=2664891705","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664891705?lang=zh_tw&edition=fundamental","pubTime":"2026-09-02 15:20","pubTimestamp":1788333621,"startTime":"0","endTime":"0","summary":"进入秋季，高盛对其美国及欧洲市场的“确信名单”进行了更新，为投资者指明当前最看好的股票方向。本次调整中，美国名单新增一只大型生物科技股，欧洲名单则迎来三家新面孔。美国名单：新增福泰制药，移除盈透证券在美国市场，高盛将 $福泰制药$纳入确信名单，同时移除了 $盈透证券$，调整后名单保留23只股票。高盛还表示，塔兰克斯的国际零售业务是被低估的增长引擎。","market":"us","thumbnail":"https://static.tigerbbs.com/1b3684302211042d481cacf9066fbcca","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/1b3684302211042d481cacf9066fbcca"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1490866.html","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["LU2237443549.SGD","BIB","SG9999001176.USD","LU2236285917.USD","GSX","IE0034235188.USD","SG9999001176.SGD","VRTX","LU0345770993.USD","LU2471134796.USD","MSFU","IBB","LU2471134523.USD","BK4533","VGK","BBH","MSFO","MSFX","GNMX","LU0106831901.USD","XYZY","WFC","LU2362541273.HKD","IE00BJT1NW94.SGD","IE0002270589.USD","EL","VXUS","MSFC","IDNA","LU2471134952.CNY","IE00B2B36J28.USD","CRNX","LU2417539215.USD","IBKR","LU1868836757.USD","UNHU","UNH","IE00BFXG1179.USD","LU2468319806.SGD","IE0004091025.USD","UNHW","LU1585245621.USD","TBXU","UN","LU2471134879.HKD","XYZ","DAL","BK4532","IE00B19Z3581.USD","IEV","XYZG","MSFT","BK4504","LU0432979614.USD","LU2750360641.GBP","BK4585","LU0889565916.HKD","COP","MSFW","MSFL","UNHG","PBE","LU0109394709.USD","LU1868837300.USD","LU1868837136.USD","LU2265009873.SGD","IE00BFTCPJ56.SGD","IBBQ","LU1069344957.HKD","MSFY","LU2456880835.USD","MSFD","BK4567"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664521258","title":"美股異動丨諾華製藥升逾7%，多發性硬化症口服藥後期臨床試驗結果積極","url":"https://stock-news.laohu8.com/highlight/detail?id=2664521258","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664521258?lang=zh_tw&edition=fundamental","pubTime":"2026-09-01 22:18","pubTimestamp":1788272338,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["LFSC","IE00B4R5TH58.HKD","LU2322448957.HKD","IE00BJJMRZ35.SGD","BIB","MEDX","BK4588","XPH","IDNA","IE0002141913.USD","RSPH","RXL","PBPH","IBRN","BBP","IE00BJT1NW94.SGD","MRNX","FBT","XBIX","BIOY","BK4585","SBIO","AZNH","PJP","MEDI","TMED","IE00BFTCPJ56.SGD","LU0211331839.USD","HELX","IEIH","FTXH","IBB","LU0070302665.USD","MRNY","IE0009355771.USD","PBE","BK4007","PPH","IEHS","BBH","SYNB","WDNA","CANC","NVS","PSCH","LU2473716301.USD","LU2272731600.USD","BME","IYH","GNOM"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664347855","title":"英國監管機構因數據不可靠，暫停安進公司Tavneos用於新患者","url":"https://stock-news.laohu8.com/highlight/detail?id=2664347855","media":"路透中文","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664347855?lang=zh_tw&edition=fundamental","pubTime":"2026-09-01 19:15","pubTimestamp":1788261324,"startTime":"0","endTime":"0","summary":"英国监管机构因数据不可靠，暂停安进公司Tavneos用于新患者路透9月1日-英国药品监管机构周二暂停了安进公司旗下AMGN.O研发的罕见病药物Tavneos对新患者的使用和销售，称支持该药获批的主要研究结果不可靠。监管机构表示，由于主要临床试验的数据不可靠，该研究已无法证明该药有效，也无法证明其益处大于风险。Tavneos由ChemoCentryx公司研发，安进公司于2022年以37亿美元收购了该公司。欧洲委员会于8月撤销了Tavneos的批准，此前监管机构发现其关键试验数据不可靠。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260901:nL4T44T10B:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TBXU","BBH","BK4588","LU2112291526.USD","BK4533","BK4566","BK7511","AMGN","BK4585","IBBQ","BIB","PBE","LU1571399168.USD","LU1983299246.USD","LU0289739699.SGD","BK4534","BK4139","IE00BJT1NW94.SGD","LU1061106388.HKD","LU2242646821.SGD","SG9999001440.SGD","BK7501","LU0058720904.USD","LU1057294990.SGD","LU0320765992.SGD","PJP","IE00BJJMRZ35.SGD","LU0122379950.USD","LU0868494617.USD","LU1023059063.AUD","LU0889565916.HKD","IE0009355771.USD","BK4581","IE0002141913.USD","LU0109394709.USD","CSL.AU","BK7067","IE00B4R5TH58.HKD","LU2089984988.USD","IE00B2B36J28.USD","LU2242652126.USD","BK7508","IE00BFTCPJ56.SGD","BK4599","LU2468319806.SGD","IBB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1148791645","title":"英國藥品與健康產品管理局：通知上市許可持有方，自9月1日起暫停新患者使用、供應及銷售Avacopan Vifor","url":"https://stock-news.laohu8.com/highlight/detail?id=1148791645","media":"美股速递","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1148791645?lang=zh_tw&edition=fundamental","pubTime":"2026-09-01 17:35","pubTimestamp":1788255329,"startTime":"0","endTime":"0","summary":"英国药品与健康产品管理局（MHRA）已正式告知上市许可持有方，关于暂停Avacopan Vifor用于新患者的使用、供应及销售的相关决定。该措施自9月1日起生效。此番调整涉及该药物的市场流通环节，意在规范其临床应用范围。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BFTCPJ56.SGD","LU2112291526.USD","PBE","LU1571399168.USD","BK4139","LU2089984988.USD","BK4585","BK4566","LU0289739699.SGD","LU0868494617.USD","BK4533","TBXU","LU0122379950.USD","BK4588","IBB","PJP","BK4599","LU2468319806.SGD","SG9999001440.SGD","LU1057294990.SGD","AMGN","LU1061106388.HKD","LU1023059063.AUD","IE00B4R5TH58.HKD","LU0058720904.USD","IBBQ","IE00BJJMRZ35.SGD","BK4581","BIB","LU2242652126.USD","LU0320765992.SGD","IE0002141913.USD","BBH","LU0109394709.USD","LU1983299246.USD","IE00B2B36J28.USD","LU0889565916.HKD","BK4534","LU2242646821.SGD","IE00BJT1NW94.SGD","IE0009355771.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664002674","title":"特朗普政府將宣佈藥品定價協議","url":"https://stock-news.laohu8.com/highlight/detail?id=2664002674","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664002674?lang=zh_tw&edition=fundamental","pubTime":"2026-09-01 00:07","pubTimestamp":1788192474,"startTime":"0","endTime":"0","summary":"特朗普政府将宣布药品定价协议预计拜耳、武田、CSL以及中型生物技术公司将达成新协议路透此前曾报导，小型制药商认为参与其中的财务激励有限美国处方药价格往往是其他发达国家的近三倍路透8月31日-白宫一名官员表示，美国总统唐纳德·特朗普  预计将于周一宣布新一轮药品定价协议，这是旨在降低美国民众医疗保健成本举措的一部分。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260831:nL4T44S1CU:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE0009355771.USD","LU0225284248.USD","LU0094547139.USD","LU1548497426.USD","GB00BDT5M118.USD","LU2602419157.SGD","WDNA","LU2089283258.USD","IE00B4JS1V06.HKD","BK4550","LU0238689110.USD","LU1035775433.USD","LU1868837300.USD","LU0109391861.USD","IE00BFSS8Q28.SGD","IE00B1BXHZ80.USD","LU0868494617.USD","LU2324357040.USD","LU0683600562.USD","LU2491050071.SGD","SG9999014898.SGD","SGXZ51526630.SGD","LU0058720904.USD","LU0256863902.USD","LU2112291526.USD","LU2756315664.SGD","LU2211815571.USD","BK4516","LU0640476718.USD","IHE","PFE","ELIL","LU1066051498.USD","LU2361045086.USD","IE00B1XK9C88.USD","LU2750360641.GBP","SG9999015945.SGD","TMED","LU1623119135.USD","LU2417539215.USD","SG9999015978.USD","IBB","LU2237443978.SGD","LU0096364046.USD","LU1023059063.AUD","IYH","LU1280957306.USD","BBH","LU0266013472.USD","SGXZ99366536.SGD","LU2237443895.HKD","LU2237438978.USD","BK4139","IE00BK4W5M84.HKD","IE00B2B36J28.USD","LU0882574139.USD","LU1323610961.USD","LU0354030438.USD","LU2242646821.SGD","LU2456880835.USD","LU2264538146.SGD","LU2265009873.SGD","LU0689472784.USD","LU2552382215.SGD","LU2168564065.EUR","SG9999002232.USD","BK4568","ILDR","BK4534","LU0109394709.USD","IE00BFSS7M15.SGD","LU0306806265.USD","LU0323591593.USD","LU0820562030.AUD","LU0823434583.USD","LU0985481810.HKD","LU1894683348.USD","LU2168564495.EUR","SG9999001440.SGD","LU1366192091.USD","LLY","LU2237443465.HKD","THNR","LU1291159041.SGD","PPH","IE00B3T34201.USD","LU0133085943.USD","LU0079474960.USD","LU0672654240.SGD","LU1883839398.USD","IE0004445015.USD","LU2063271972.USD","IE00BLSP4239.USD","LU1069344957.HKD","LU1720051017.SGD","LU0353189763.USD","LU0097036916.USD","AGNG","LU1720051108.HKD","GDOC","SG9999018857.SGD","LU0820561818.USD","LU1232071149.USD","LU1551013342.USD","LU1917777945.USD","LU2087625088.SGD","LU2471134952.CNY","SG9999002224.SGD","LU0345770993.USD","LU0106261372.USD","VHT","LU1989771016.USD","LU2896262040.SGD","LU1629891620.HKD","LU0964807845.USD","LU1814569148.SGD","LU0158827948.USD","LU2491050154.USD","LU0321505439.SGD","PJP","LU2237443549.SGD","RXL","LU0432979614.USD","TBXU","IXJ","LLYX","LU0225283273.USD","LU0210536198.USD","LU0471298777.SGD","LU1145028129.USD","LU2462591350.SGD","IE0001KFT4U8.USD","MEDI","LU0456855351.SGD","SGXZ81514606.USD","LU2168564149.EUR","LLYZ","LU0006306889.USD","LU0225771236.USD","LU2028103732.USD","LU0385154629.USD","LU2552382132.HKD","IE0002270589.USD","BK7508","LU2111349929.HKD","IE00BBT3K403.USD","LU1267930730.SGD","SG9999001176.USD","SG9999003800.SGD","PBE","LU0321505868.SGD","BK4007","LU2361044949.HKD","LU0823434740.USD","LU1057294990.SGD","LU1093756168.USD","LU0170899867.USD","LU0354030511.USD","LU2462157665.USD","IE00BKPKM429.USD","LU0471298694.HKD","IE00B7KXQ091.USD","IE00BK4W5L77.USD","IE00B19Z3B42.SGD","LU0466842654.USD","LU1064131342.USD","LU0320765059.SGD","IE00BFTCPJ56.SGD","LU2271345857.HKD","LU0820561909.HKD","LU0289739699.SGD","IE00BJT1NW94.SGD","LU0114720955.EUR","LU0882574055.USD","BK4585","LU1974910355.USD","LU1983299246.USD","LU1093756325.SGD","BK4599","LU1691799644.USD","LU1988902786.USD","IE00BN29S564.USD","BK7501","LU0353189680.USD","IE00BJJMRX11.SGD","LU1894683264.USD","JDOC","LU0943347566.SGD","SGXZ31699556.SGD","04332","LU0234572021.USD","MHIP","SG9999001176.SGD","BK4533","HRTS","LU0316494557.USD","BK4588","CURE","IE00B775H168.HKD","IE00BJJMRZ35.SGD","LU1868837136.USD","IE00BWXC8680.SGD","LU2471134523.USD","AMGN","LU1868836591.USD","IE00B19Z3581.USD","FHLC","IE0002141913.USD","IE00BJLML261.HKD","LU1712237335.SGD","LU0122379950.USD","LU2023250330.USD","CANC","IE00BJJMRY28.SGD","LU2168564222.USD","LU2089984988.USD","SG9999011175.SGD","SG9999014880.SGD","LU2756315318.SGD","OZEM","SG9999015986.USD","BK7067","LU2237443622.USD","BK4566","LU2471134879.HKD","LU0417517546.SGD","IONS","LU0889565916.HKD","LU2108987350.USD","TRUH","LU2023250504.SGD","LU1066053197.SGD","LU1061106388.HKD","LU1868836914.USD","LU2236285917.USD","LU2237443382.USD","LU2360106947.USD","BK4581","LU0345770308.USD","IE0005OL40V9.USD","LU0061475181.USD","LU2461242641.AUD","LU0174119429.USD","SG9999017495.SGD","LU2106854487.HKD","SG9999014914.USD","LU2023251221.USD","LU2168563687.JPY","CSL.AU","LU1127390331.HKD","LU2491049909.HKD","LU2750360997.AUD","LU2357305700.SGD","IE000M9KFDE8.USD","SG9999014906.USD","SG9999018865.SGD","BIB","SGXZ57979304.SGD","LU0203201768.USD","IE00BLSP4452.SGD","LU1979441026.SGD","LU0158827781.USD","LU2471134796.USD","LU1804176565.USD","IE00B4R5TH58.HKD","IE00BKDWB100.SGD","LU2468319806.SGD","LU0198837287.USD","BK4592","LU0203202063.USD","FTXH","LU2089284900.SGD","SG9999015952.SGD","LLII","LU0306807586.USD","SG9999013999.USD","LU0786609619.USD","LU2361044865.SGD","LU1551013425.SGD","LU0787776722.HKD","LU0823416689.USD","IE0004445239.USD","LU2746668461.USD","XLV","LU1868836757.USD","LU0256863811.USD","LU2242652126.USD","IBBQ","LU0708995401.HKD","LU1571399168.USD","LU2552382058.USD","LU2596442595.SGD","LU2213496289.HKD","ELIS","BK7511","LU2746668974.SGD","MEDX","LU0320765992.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663778550","title":"安進（AMGN）降脂藥Repatha新臨床數據：可降低未發生心梗或中風高危患者20%死亡風險","url":"https://stock-news.laohu8.com/highlight/detail?id=2663778550","media":"金吾财讯","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663778550?lang=zh_tw&edition=fundamental","pubTime":"2026-08-31 18:48","pubTimestamp":1788173287,"startTime":"0","endTime":"0","summary":"研究结果显示，对于既往未发生过心肌梗死或中风的高危成年患者，在接受他汀类或其他降脂疗法的基础上加用Repatha，可显著降低20%的全因死亡风险，同时有效降低心血管死亡率。数据显示，Repatha能在治疗开启最早6个月内降低心梗风险，且将患者低密度脂蛋白胆固醇中位数降低至45mg/dL，远优于安慰剂组的109mg/dL。此外，欧盟委员会已于2026年8月批准扩大Repatha在欧洲的适应症，用于确诊或高危确诊的动脉粥样硬化性心血管疾病成年患者降低心血管风险。","market":"hk","thumbnail":"https://static.szfiu.com/news/20250107/Mjk1NzA2YjQxMDg1MTQ0MjI1MzE=.png","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20250107/Mjk1NzA2YjQxMDg1MTQ0MjI1MzE=.png"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"305491","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4533","IE00B2B36J28.USD","LU0109394709.USD","LU0058720904.USD","BK4588","LU0868494617.USD","IE00B4R5TH58.HKD","TBXU","BK4581","LU0122379950.USD","IBB","IE0002141913.USD","IE0009355771.USD","PBE","LU2242652126.USD","IE00BJT1NW94.SGD","LU0320765992.SGD","BK4599","LU0289739699.SGD","SG9999001440.SGD","IE00BJJMRZ35.SGD","LU2468319806.SGD","IE00BFTCPJ56.SGD","AMGN","LU0889565916.HKD","LU2112291526.USD","BBH","LU1983299246.USD","PJP","BK4534","IBBQ","LU1023059063.AUD","BK4139","BK4566","LU2089984988.USD","BIB","LU1061106388.HKD","LU1057294990.SGD","BK4585","LU1571399168.USD","LU2242646821.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663282078","title":"藥聞 | 英硅智能上市後首份半年報扭虧 創新藥研發加速擁抱AI","url":"https://stock-news.laohu8.com/highlight/detail?id=2663282078","media":"新华财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663282078?lang=zh_tw&edition=fundamental","pubTime":"2026-08-31 15:35","pubTimestamp":1788161758,"startTime":"0","endTime":"0","summary":"新华财经上海8月31日电（记者杜康）作为AI制药领域代表性企业之一，英硅智能（03696.HK）日前发布2026年度中期业绩报告。上半年，公司实现总营收1.063亿美元，同比增长287.2%；净利润3554万美元，经调整净利润5123万美元，经营活动现金流转正。这是英硅智能上市后发布的首份半年报，公司也由此前的亏损转为盈利。从收入结构看，药物研发与管线开发仍是主要来源。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202608313860072952.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202608313860072952.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["APXH","GSKH","BK4585","AGIX","QTOC","WRND","PBE","XLVI","AIPO","BBP","IBB","ARTY","BK4588","BIOY","GDOC","CHAT","VTHR","SBIO","LFSC","IPOS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663044177","title":"聯環藥業上半年扭虧為盈 集採續採與創新藥研發協同推進","url":"https://stock-news.laohu8.com/highlight/detail?id=2663044177","media":"证券日报 ","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663044177?lang=zh_tw&edition=fundamental","pubTime":"2026-08-30 21:12","pubTimestamp":1788095520,"startTime":"0","endTime":"0","summary":"业绩实现扭亏为盈经营基本面持续改善今年上半年，联环药业经营业绩实现明显改善。对此，联环药业正持续推进相关工作。值得注意的是，联环药业已经开始围绕创新药商业化进行营销体系布局。除LH-1801外，联环药业产品注册申报也取得阶段性进展。从核心产品稳定销售，到集采品种持续放量，再到创新药研发向上市申报环节推进，联环药业正在逐步形成多层次的业务增长支撑。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/stock/relnews/cn/2026-08-30/doc-iniqcfmp8061523.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/relnews/cn/2026-08-30/doc-iniqcfmp8061523.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["IBB","600513","LFSC","BBP","BK0239","GSKH","BIOY","GDOC","WRND","XLVI","PBE","BK4588","BK4585","SBIO","APXH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662060177","title":"台裕製藥提交針對HER2陽性乳腺癌的抗體藥物偶聯物生物類似藥TSY-110的臨床試驗申請。","url":"https://stock-news.laohu8.com/highlight/detail?id=2662060177","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662060177?lang=zh_tw&edition=fundamental","pubTime":"2026-08-28 20:03","pubTimestamp":1787918605,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["LU2272731600.USD","LU2322448791.USD","IBBQ","IBB","IE00B5TLWC47.USD","LU1992135399.USD","IBBJ","BK4585","LU1992135472.HKD","LU2272731865.HKD","BK4588","XPH","BMED","LU2473716301.USD","LU2322448957.HKD","LU2272731782.SGD","PSYK","MDTX","PPH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662036374","title":"美國食品藥品監督管理局（FDA）批准吉利德治療艾滋病的每日一次複方片劑","url":"https://stock-news.laohu8.com/highlight/detail?id=2662036374","media":"路透中文","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662036374?lang=zh_tw&edition=fundamental","pubTime":"2026-08-28 05:50","pubTimestamp":1787867453,"startTime":"0","endTime":"0","summary":"美国食品药品监督管理局（FDA）批准吉利德治疗艾滋病的每日一次复方片剂路透8月27日-吉利德科学公司周四表示，美国食品和药物管理局已批准该公司研发的每日一次口服复方药GILD.O，用于治疗HIV病毒载量已降至极低水平的成人患者。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260827:nL4S44O24V:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4583","LU1023059063.AUD","SG9999015945.SGD","SG9999015986.USD","IBB","LU1778281490.HKD","LU0965508806.USD","LU1430594728.SGD","LU2112291526.USD","TBXU","LU0058720904.USD","LU2324357040.USD","LU1839511570.USD","LU1037948541.HKD","TMED","BMED","BK4139","LU0114720955.EUR","LU0289739699.SGD","IE00B19Z3581.USD","IE00B3T34201.USD","BK4568","LU1066053197.SGD","IBBQ","SG9999015952.SGD","LU0965509283.SGD","IE00BZ1G4Q59.USD","LU0965509101.SGD","LU1037948897.HKD","LU1571399168.USD","BIB","LU2468319806.SGD","LU0889565916.HKD","LU1934455277.USD","BK4585","LU0109394709.USD","LU0861579265.USD","SG9999015978.USD","LU1061106388.HKD","GILD","LU1674673691.USD","IE00BKVL7J92.USD","BK4566","IE0002270589.USD","BK4532","BBH","LU1934455194.USD","IE00B7SZLL34.SGD","LU0823416689.USD","MEDI"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":3,"totalSize":200,"code":"91000000","status":"200"}]}}